Jump to content

LMO4

From Wikipedia, the free encyclopedia
LMO4
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesLMO4, LIM domain only 4
External IDsOMIM: 603129; MGI: 109360; HomoloGene: 4927; GeneCards: LMO4; OMA:LMO4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_006769
NM_001369491

NM_001161769
NM_001161770
NM_010723

RefSeq (protein)

NP_006760
NP_001356420

NP_001155241
NP_001155242
NP_034853

Location (UCSC)Chr 1: 87.33 – 87.35 MbChr 3: 143.89 – 143.91 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

LIM domain transcription factor LMO4 is a protein that in humans is encoded by the LMO4 gene.[5]

LIM domain only 4 is a cysteine-rich, two LIM domain-containing protein that may play a role as a transcriptional regulator or possibly an oncogene. Its mRNA is characterized by a GC-rich 5' region and by multiple ATTT motifs in the 3' region. A variant transcript missing a portion of the 5' region has been identified but cannot be confirmed because of the GC-rich nature of the region.[5]

Clinical Significance

[edit]

LMO4 has garnered significant attention for its involvement in cancer, particularly breast cancer.[6] It is overexpressed in a substantial percentage of primary breast carcinomas.[7] Studies have shown that LMO4 can promote the proliferation of mammary epithelial cells, inhibit their differentiation, and enhance cell invasion and motility, all of which are hallmarks of cancer progression.

Interactions

[edit]

LMO4 has been shown to interact with LDB1,[8][9] RBBP8[8][10] and BRCA1.[8][10]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000143013Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028266Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: LMO4 LIM domain only 4".
  6. ^ Singh, Rajesh R.; Barnes, Christopher J.; Talukder, Amjad H.; Fuqua, Suzanne A.W.; Kumar, Rakesh (2005-11-15). "Negative Regulation of Estrogen Receptor α Transactivation Functions by LIM Domain Only 4 Protein". Cancer Research. 65 (22): 10594–10601. doi:10.1158/0008-5472.CAN-05-2268. ISSN 0008-5472.
  7. ^ Sum, Eleanor Y. M.; Segara, Davendra; Duscio, Belinda; Bath, Mary L.; Field, Andrew S.; Sutherland, Robert L.; Lindeman, Geoffrey J.; Visvader, Jane E. (2005-05-24). "Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer". Proceedings of the National Academy of Sciences. 102 (21): 7659–7664. doi:10.1073/pnas.0502990102. ISSN 0027-8424. PMC 1140463.
  8. ^ a b c Sutherland, Kate D; Visvader Jane E; Choong David Y H; Sum Eleanor Y M; Lindeman Geoffrey J; Campbell Ian G (Oct 2003). "Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas". Int. J. Cancer. 107 (1): 155–8. doi:10.1002/ijc.11343. ISSN 0020-7136. PMID 12925972.
  9. ^ Deane, Janet E; Mackay Joel P; Kwan Ann H Y; Sum Eleanor Y M; Visvader Jane E; Matthews Jacqueline M (May 2003). "Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4". EMBO J. 22 (9): 2224–33. doi:10.1093/emboj/cdg196. ISSN 0261-4189. PMC 156068. PMID 12727888.
  10. ^ a b Sum, Eleanor Y M; Peng Benjamin; Yu Xin; Chen Junjie; Byrne Jennifer; Lindeman Geoffrey J; Visvader Jane E (Mar 2002). "The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity". J. Biol. Chem. 277 (10): 7849–56. doi:10.1074/jbc.M110603200. ISSN 0021-9258. PMID 11751867.

Further reading

[edit]